Resumen
Background Exercise-based cardiac rehabilitation (CR) participation results in increased cardio-metabolic fitness, which is associated with reduced mortality. However, many graduates fail to maintain exercise post-program. ECO-PCR investigates the efficacy and cost-effectiveness of a social ecologically-based intervention to increase long-term exercise maintenance following the completion of CR. Methods/design A three-site, 2-group, parallel randomized controlled trial is underway. 412 male and 192 female (N = 604) supervised CR participants are being recruited just before CR graduation. Participants are randomized (1:1 concealed allocation) to intervention or usual care. A 50-week exercise facilitator intervention has been designed to assist CR graduates in the transition from structured, supervised exercise to self-managed home- or community-based (e.g., Heart Wise Exercise programs) exercise. The intervention consists of 8 telephone contacts over the 50 week period: 3 individual and 5 group. Assessments occur at CR graduation, and 26, 52 and 78 weeks post-randomization. The primary outcome is change in minutes of accelerometer-measured moderate to vigorous-intensity physical activity (MVPA) from CR graduation to 52 weeks post-randomization. Secondary measures include exercise capacity, quality of life, and cardiovascular risk factors. Analyses will be undertaken based on intention-to-treat. For the primary outcome, an analysis of variance will be computed to test the change in minutes of MVPA in each group between CR graduation and 52 week follow-up (2 [arm] × 2 [time]). Secondary objectives will be assessed using mixed-model repeated measures analyses to compare differences between groups over time. Mean costs and quality-adjusted life years for each arm will be estimated.
Idioma original | English |
---|---|
Páginas (desde-hasta) | 116-123 |
Número de páginas | 8 |
Publicación | Contemporary Clinical Trials |
Volumen | 50 |
DOI | |
Estado | Published - sep. 1 2016 |
Nota bibliográfica
Funding Information:Funding: This work has been supported by the Heart and Stroke Foundation of Canada [grant # G-14-0006126 ]. The funder has no role in the conduct of the study.
Publisher Copyright:
© 2016 Elsevier Inc.
ASJC Scopus Subject Areas
- Pharmacology (medical)
PubMed: MeSH publication types
- Journal Article
- Randomized Controlled Trial
- Research Support, Non-U.S. Gov't